pharmacists mutual insurance company

LexisNexis® Mealey's™ Conferences
Legal Conferences from LexisNexis®

• LexisNexis Presents: Defense Strategies in Pharmaceutical Litigation Conference, January 31 - February 1, 2005 - An Industry under Siege - Attack Themes and How to Respond
  John Lavelle of Ballard Spahr Andrews & Ingersoll; John Getsinger, Senior Legal Counsel, Litigation of Medtronic Inc.; and Frederick Fern of Harris Beach give an overview of the latest themes attacking pharmaceutical manufacturers in news and mass media and in the courtroom, including plaintiffs' attacks on research and development, clinical testing, sales and marketing, and protection of intellectual property. In addition, Mr. Lavelle, Mr. Getsinger, and Mr. Fern also review how to anticipate and respond to these new lines of attack.
• LexisNexis Presents: Defense Strategies in Pharmaceutical Litigation Conference, January 31 - February 1, 2005 - Effective Strategies in Cases Involving the Treating Physician
  Thomas Mazziotti of Alston & Bird and Joseph Morton of Duplass Zwain Bourgeois & Morton discuss how to deal with physicians who are co-defendants in the litigation and how to best handle cases in which the physician is a non-party witness. In addition, Mr. Mazziotti and Mr. Morton review diagnosis in medical records, specifically the problems of the suggestive patient/prospective plaintiff.
• LexisNexis Presents: Defense Strategies in Pharmaceutical Litigation Conference, January 31 - February 1, 2005 - The Learned Intermediary Doctrine - Is it Eroding?
  William Corley of Marks Gray and Frank Woodside of Dinsmore & Shohl discuss "overpromotion" theories specifically where they come from and how to defend against them. Mr. Corley and Mr. Woodside also review direct to consumer advertising, consumer fraud claims, FDA mandated warnings to patients, and updates that have occurred in the Perez case.
• LexisNexis Presents: Defense Strategies in Pharmaceutical Litigation Conference, January 31 - February 1, 2005 - Counterfeits: What can a Drug Manufacturer Do?
  Diane Sullivan of Dechert discusses what a company can do when a competitor makes a phony drug and markets it under your label as well as what a manufacturer's potential liability is for product tampering.
• LexisNexis Presents: Defense Strategies in Pharmaceutical Litigation Conference, January 31 - February 1, 2005 - Preemption: Current Case Law and Developments
  Ernest Bernabei of Harvey Pennington Ltd. and Lawrence Purdy of Maslon Edelman Borman & Brand give an update of the state of the law on preemption specifically, new developments, off-label use, medical devices, and pharmaceuticals. Mr. Bernabei and Mr. Purdy also review the latest efforts to evade preemption decisions specifically, the controversy over FDA as amicus and restyling of claims.
• LexisNexis Presents: Defense Strategies in Pharmaceutical Litigation Conference, January 31 - February 1, 2005 - Forum Selection: Update on Legal Developments
  Mark Miller of Wildman Harrold Allen & Dixon discusses removal and remand, specifically fraudulent joinder to defeat diversity and complete preemption, as well as forum no conveniens and strategic and tactical considerations.
• LexisNexis Presents: Defense Strategies in Pharmaceutical Litigation Conference, January 31 - February 1, 2005 - Punitive Damages after State Farm v. Campbell
  Bruce Clark of Dechert reviews the effects State Farm v. Campbell has had on the state of punitive damages.
• Mealey's Third Annual Advanced Insurance Coverage Conference: Top 10 Issues, January 24-25, 2005 - Allocation Concepts: Beyond the Traditional Issues
  Benedict Lenhart of Covington & Burling, John Duchelle of Ross Dixon & Bell and Paul Breene of Anderson Kill & Olick discuss allocation when an insurer has a duty to defend specifically, between covered and uncovered claims and between offensive and defensive claims. Mr. Lenhart, Mr. Duchelle, and Mr. Breene also review allocation when an insurer must indemnify or advance defense costs as well as give an analysis of the most recent cases.
• Mealey's Third Annual Advanced Insurance Coverage Conference: Top 10 Issues, January 24-25, 2005 - Liquidation and the Claims Process: Making the Best Out of a Bad Situation
  Richard McMenamin of Morgan Lewis gives an analysis of the liquidation process and reviews policyholder strategies to maximize its recovery from an insurer being liquidated.
• Mealey's Third Annual Advanced Insurance Coverage Conference: Top 10 Issues, January 24-25, 2005 - Dealing with a Bankrupt Policyholder
  Richard Milone of Gilbert Heintz & Randolph and Roger Warin of Steptoe & Johnson discuss what the implications are when the policyholder is bankrupt as well as the latest in D&O, asbestos & other claims scenarios.
• Mealey's Third Annual Advanced Insurance Coverage Conference: Top 10 Issues, January 24-25, 2005 - Coverage Litigation - The Thought Process From All Sides: A Panel Discussion
  Lori Siwik, Vice President & Counsel of Risk International Services, Inc., moderates as Kevin Quinley, CPCU, AIC, Senior Vice President of Medmarc Insurance Group; Elit Felix of Margolis Edelstein; and Kenneth Ross, Senior Vice President of Willis New York, Inc., discuss all perspectives of coverage litigation.
• Mealey's Third Annual Advanced Insurance Coverage Conference: Top 10 Issues, January 24-25, 2005 - D&O Issues
  Matthew Schlesinger of Reed Smith and Dan Brown of Bickel & Brewer give an analysis of the most recent D&O cases and discuss how courts have dealt with rescission, severability, the conduct exclusions and more in the corporate scandal cases. Mr. Schlesinger and Mr. Brown also review emerging issues in Side A only coverage.